Successful treatment of Aspergillus fumigatus ...
Type de document :
Compte-rendu et recension critique d'ouvrage
DOI :
PMID :
Titre :
Successful treatment of Aspergillus fumigatus sternal osteomyelitis with isavuconazole in a heart transplant recipient
Auteur(s) :
Assaf, Ady [Auteur correspondant]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Faure, Emmanuel [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Sermet, Kevin [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Loridant, Severine [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Leroy, Jordan [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Goeminne, Celine [Auteur]
Hôpital cardiologique
Dozier, Aurelie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Chopin, Marie‐charlotte [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Panaget, Sophie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Faure, Karine [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Vuotto, Fanny [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Faure, Emmanuel [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Sermet, Kevin [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Loridant, Severine [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Leroy, Jordan [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Goeminne, Celine [Auteur]
Hôpital cardiologique
Dozier, Aurelie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Chopin, Marie‐charlotte [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Panaget, Sophie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Faure, Karine [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Vuotto, Fanny [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Titre de la revue :
TRANSPLANT INFECTIOUS DISEASE
Pagination :
e13313
Éditeur :
Wiley
Date de publication :
2020-05-09
ISSN :
1398-2273
Mot(s)-clé(s) en anglais :
aspergillosis
heart transplantation
isavuconazole
sternal osteomyelitis
heart transplantation
isavuconazole
sternal osteomyelitis
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
A 65-year-old man was diagnosed with an invasive Aspergillus fumigatus infection with sternal osteomyelitis 4 months after heart transplantation. Unfortunately, after 8 weeks patient developed severe cutaneous and neurological ...
Lire la suite >A 65-year-old man was diagnosed with an invasive Aspergillus fumigatus infection with sternal osteomyelitis 4 months after heart transplantation. Unfortunately, after 8 weeks patient developed severe cutaneous and neurological toxicities induced by voriconazole leading to drug discontinuation. Therefore, isavuconazole was chosen as second-line therapy. The patient presented a favorable outcome and tolerance was excellent after ten months monotherapy. Here, we report for a first time, an successful isavuconazole-based treatment of sternal osteomyelitis aspergillosis in a cardiac recipient.Lire moins >
Lire la suite >A 65-year-old man was diagnosed with an invasive Aspergillus fumigatus infection with sternal osteomyelitis 4 months after heart transplantation. Unfortunately, after 8 weeks patient developed severe cutaneous and neurological toxicities induced by voriconazole leading to drug discontinuation. Therefore, isavuconazole was chosen as second-line therapy. The patient presented a favorable outcome and tolerance was excellent after ten months monotherapy. Here, we report for a first time, an successful isavuconazole-based treatment of sternal osteomyelitis aspergillosis in a cardiac recipient.Lire moins >
Langue :
Anglais
Vulgarisation :
Non
Source :